
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Sec61β CRISPR/Cas9 KO Plasmid (m) | sc-425892 | 20 µg | $397.00 |
SEC61B encodes the beta subunit of the Sec61 translocon, a core component of the endoplasmic reticulum (ER) membrane channel that mediates co-translational protein import and integration of nascent polypeptides into the secretory pathway. In mouse cells, Sec61β supports ER protein biogenesis, coordinates with ribosome docking, and contributes to ER proteostasis processes linked to folding and ER-associated degradation (ERAD). Altered translocon function can perturb secretion, membrane protein homeostasis, and unfolded protein response signaling, connecting SEC61 complex activity to cellular stress adaptation. Because secretory pathway integrity underlies immune signaling, metabolism, and neuronal function, Sec61b is frequently studied in the context of proteostasis imbalance and stress-related disease mechanisms.
Sec61β CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Sec61b gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Sec61b together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Sec61b open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Sec61β protein expression.
This CRISPR knockout system enables efficient generation of Sec61b-deficient cell models for investigation of Sec61β signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.